Tumour escape from the immune response

By Pawelec G.  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 843-843

Springer Publishing Company

Access to resources Recommend Favorite

Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 4, 2014-05 ,pp. : 607-617

Bentham Science Publishers

Access to resources Recommend Favorite

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity

By Todryk Stephen   Eaton Jonathan   Birchall Lindsay   Greenhalgh Rebecca   Soars Diane   Dalgleish Angus   Melcher Alan   Pandha Hardev  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 323-330

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice

By Sirova Milada   Strohalm Jiri   Subr Vladimir   Plocova Daniela   Rossmann Pavel   Mrkvan Tomas   Ulbrich Karel   Rihova Blanka  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 35-47

Springer Publishing Company

Access to resources Recommend Favorite

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts

By Hill B.T.   Fiebig H.-H.   Waud W.R.   Poupon M.-F.   Colpaert F.   Kruczynski A.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 512-520

Elsevier

Access to resources Recommend Favorite